Status:

Do Not Prescribe (DNP)

Decision Date:

February 2026

Comments

NICE TA1123: (Terminated appraisal) Depemokimab for treating chronic rhinosinusitis with nasal polyps in adults

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again